To further test our hypothesis of FBLN2′s positive contribution to controlling cancer growth and progression we assessed whether high Fbln2 mRNA expression correlated with improved distant-metastasis-free survival (DMFS) in patients with breast cancer of different grades and LN status, using the Kaplan Meier plotter dataset27 (Supplementary Fig. 5). Here, FBLN2 is linked to breast carcinoma.